VA
ABBV icon

Verdad Advisers’s AbbVie ABBV Stock Holding History

Verdad Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$676K Buy
+3,422
New +$639K 0.9% 40
2024
Q2 		– Sell
-2,484
Closed -$452K – 111
2024
Q1 		$452K Buy
+2,484
New +$428K 0.49% 78

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Verdad Advisers's ABBV Position: Q3 2024 in Review

Verdad Advisers opened a new position in AbbVie (ABBV) in Q3 2024: 3,422 shares worth $676K. The stake represents 0.9% of the portfolio and ranks #40 among its holdings. This is a return to the name: Verdad Advisers previously reported a position in ABBV as recently as Q1 2024.

Verdad Advisers first reported a position in ABBV in Q1 2024 and has held it in 2 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Verdad Advisers held 3,422 shares of AbbVie worth $676K as of Q3 2024.
  • AbbVie was a new Verdad Advisers position in Q3 2024.
  • AbbVie made up 0.9% of Verdad Advisers's portfolio in Q3 2024, its #40 holding.
  • Verdad Advisers first reported a position in AbbVie in Q1 2024 and has held it in 2 quarters since.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Verdad Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.